Select Medical Holdings (NYSE:SEM) reported Q4 EPS of $0.22, $0.14 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.58 billion.
GUIDANCE:
Select Medical Holdings sees FY2023 revenue of $6.5-6.7 billion, versus the consensus of $6.644 billion.